Logo image of RPAY

REPAY HOLDINGS CORP (RPAY) Stock Fundamental Analysis

NASDAQ:RPAY - Nasdaq - US76029L1008 - Common Stock - Currency: USD

5.87  -0.09 (-1.51%)

After market: 5.87 0 (0%)

Fundamental Rating

4

Taking everything into account, RPAY scores 4 out of 10 in our fundamental rating. RPAY was compared to 101 industry peers in the Financial Services industry. While RPAY seems to be doing ok healthwise, there are quite some concerns on its profitability. RPAY is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

RPAY had positive earnings in the past year.
In the past year RPAY had a positive cash flow from operations.
In the past 5 years RPAY reported 4 times negative net income.
In the past 5 years RPAY always reported a positive cash flow from operatings.
RPAY Yearly Net Income VS EBIT VS OCF VS FCFRPAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

1.2 Ratios

RPAY's Return On Assets of -0.65% is on the low side compared to the rest of the industry. RPAY is outperformed by 81.19% of its industry peers.
With a Return On Equity value of -1.33%, RPAY is not doing good in the industry: 80.20% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.65%
ROE -1.33%
ROIC N/A
ROA(3y)-2.38%
ROA(5y)-3.92%
ROE(3y)-4.49%
ROE(5y)-7.98%
ROIC(3y)N/A
ROIC(5y)N/A
RPAY Yearly ROA, ROE, ROICRPAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

The Gross Margin of RPAY (77.12%) is better than 84.16% of its industry peers.
RPAY's Gross Margin has been stable in the last couple of years.
RPAY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.07%
GM growth 5Y0.49%
RPAY Yearly Profit, Operating, Gross MarginsRPAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

5

2. Health

2.1 Basic Checks

RPAY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RPAY has been reduced compared to 1 year ago.
RPAY has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, RPAY has a worse debt to assets ratio.
RPAY Yearly Shares OutstandingRPAY Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
RPAY Yearly Total Debt VS Total AssetsRPAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 0.44, we must say that RPAY is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.44, RPAY is in line with its industry, outperforming 47.52% of the companies in the same industry.
RPAY has a debt to FCF ratio of 4.72. This is a neutral value as RPAY would need 4.72 years to pay back of all of its debts.
The Debt to FCF ratio of RPAY (4.72) is better than 66.34% of its industry peers.
RPAY has a Debt/Equity ratio of 0.65. This is a neutral value indicating RPAY is somewhat dependend on debt financing.
RPAY has a Debt to Equity ratio (0.65) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.72
Altman-Z 0.44
ROIC/WACCN/A
WACC9.06%
RPAY Yearly LT Debt VS Equity VS FCFRPAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.69 indicates that RPAY has no problem at all paying its short term obligations.
The Current ratio of RPAY (2.69) is better than 83.17% of its industry peers.
A Quick Ratio of 2.69 indicates that RPAY has no problem at all paying its short term obligations.
The Quick ratio of RPAY (2.69) is better than 84.16% of its industry peers.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 2.69
RPAY Yearly Current Assets VS Current LiabilitesRPAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

RPAY shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.75%.
The Earnings Per Share has been growing slightly by 3.49% on average over the past years.
RPAY shows a small growth in Revenue. In the last year, the Revenue has grown by 5.53%.
The Revenue has been growing by 24.51% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)5.75%
EPS 3Y3.49%
EPS 5YN/A
EPS Q2Q%-11.11%
Revenue 1Y (TTM)5.53%
Revenue growth 3Y12.6%
Revenue growth 5Y24.51%
Sales Q2Q%3%

3.2 Future

The Earnings Per Share is expected to grow by 7.74% on average over the next years.
The Revenue is expected to grow by 6.93% on average over the next years.
EPS Next Y7.65%
EPS Next 2Y7.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.47%
Revenue Next 2Y4.28%
Revenue Next 3Y6.93%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
RPAY Yearly Revenue VS EstimatesRPAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
RPAY Yearly EPS VS EstimatesRPAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.38, the valuation of RPAY can be described as very cheap.
Based on the Price/Earnings ratio, RPAY is valued cheaply inside the industry as 88.12% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 29.35. RPAY is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 5.93, which indicates a rather cheap valuation of RPAY.
RPAY's Price/Forward Earnings ratio is rather cheap when compared to the industry. RPAY is cheaper than 89.11% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. RPAY is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.38
Fwd PE 5.93
RPAY Price Earnings VS Forward Price EarningsRPAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

RPAY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. RPAY is cheaper than 73.27% of the companies in the same industry.
RPAY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. RPAY is cheaper than 91.09% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.44
EV/EBITDA 9.17
RPAY Per share dataRPAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.83
PEG (5Y)N/A
EPS Next 2Y7.74%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

RPAY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

REPAY HOLDINGS CORP

NASDAQ:RPAY (3/7/2025, 8:00:02 PM)

After market: 5.87 0 (0%)

5.87

-0.09 (-1.51%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-03 2025-03-03/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners100.28%
Inst Owner Change3.41%
Ins Owners6.11%
Ins Owner Change6.7%
Market Cap572.27M
Analysts76.47
Price Target11.36 (93.53%)
Short Float %9.21%
Short Ratio13.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.03
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.44%
Min EPS beat(2)-5.01%
Max EPS beat(2)0.14%
EPS beat(4)2
Avg EPS beat(4)-1.89%
Min EPS beat(4)-5.01%
Max EPS beat(4)1.08%
EPS beat(8)3
Avg EPS beat(8)1.22%
EPS beat(12)5
Avg EPS beat(12)-0.34%
EPS beat(16)9
Avg EPS beat(16)4.49%
Revenue beat(2)0
Avg Revenue beat(2)-4.34%
Min Revenue beat(2)-6.77%
Max Revenue beat(2)-1.91%
Revenue beat(4)1
Avg Revenue beat(4)-2.95%
Min Revenue beat(4)-6.77%
Max Revenue beat(4)0.41%
Revenue beat(8)4
Avg Revenue beat(8)0.34%
Revenue beat(12)6
Avg Revenue beat(12)-0.06%
Revenue beat(16)9
Avg Revenue beat(16)0.43%
PT rev (1m)0%
PT rev (3m)-2.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.24%
EPS NY rev (1m)0%
EPS NY rev (3m)0.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.38
Fwd PE 5.93
P/S 1.83
P/FCF 5.44
P/OCF 3.81
P/B 0.75
P/tB N/A
EV/EBITDA 9.17
EPS(TTM)0.92
EY15.67%
EPS(NY)0.99
Fwd EY16.87%
FCF(TTM)1.08
FCFY18.39%
OCF(TTM)1.54
OCFY26.23%
SpS3.21
BVpS7.81
TBVpS-3.53
PEG (NY)0.83
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.65%
ROE -1.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.12%
FCFM 33.62%
ROA(3y)-2.38%
ROA(5y)-3.92%
ROE(3y)-4.49%
ROE(5y)-7.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.07%
GM growth 5Y0.49%
F-Score6
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.72
Debt/EBITDA 5.18
Cap/Depr 43.25%
Cap/Sales 14.33%
Interest Coverage N/A
Cash Conversion 156.44%
Profit Quality N/A
Current Ratio 2.69
Quick Ratio 2.69
Altman-Z 0.44
F-Score6
WACC9.06%
ROIC/WACCN/A
Cap/Depr(3y)47.31%
Cap/Depr(5y)41.61%
Cap/Sales(3y)16.73%
Cap/Sales(5y)15.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.75%
EPS 3Y3.49%
EPS 5YN/A
EPS Q2Q%-11.11%
EPS Next Y7.65%
EPS Next 2Y7.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.53%
Revenue growth 3Y12.6%
Revenue growth 5Y24.51%
Sales Q2Q%3%
Revenue Next Year0.47%
Revenue Next 2Y4.28%
Revenue Next 3Y6.93%
Revenue Next 5YN/A
EBIT growth 1Y61.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33187.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y168.1%
FCF growth 3Y52.25%
FCF growth 5Y51.08%
OCF growth 1Y44.85%
OCF growth 3Y41.19%
OCF growth 5Y47.79%